At the time of writing, Elanco Animal Health Inc [ELAN] stock is trading at $14.3, up 3.92%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The ELAN shares have gain 7.28% over the last week, with a monthly amount glided 8.50%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Elanco Animal Health Inc [NYSE: ELAN] stock has seen the most recent analyst activity on June 26, 2025, when William Blair upgraded its rating to a Outperform. Previously, UBS started tracking the stock with Buy rating on December 09, 2024, and set its price target to $18. On December 02, 2024, Leerink Partners initiated with a Market Perform rating and assigned a price target of $14 on the stock. Morgan Stanley downgraded its rating to a Equal-Weight and decreased its price target to $15 on September 19, 2024. Stifel upgraded its rating to a Buy and raised its price target to $20 on January 05, 2024. Jefferies started tracking with a Buy rating for this stock on December 19, 2023, and assigned it a price target of $17. In a note dated December 15, 2023, Morgan Stanley upgraded an Overweight rating on this stock but restated the target price of $16.
For the past year, the stock price of Elanco Animal Health Inc fluctuated between $8.02 and $18.09. Currently, Wall Street analysts expect the stock to reach $11.5 within the next 12 months. Elanco Animal Health Inc [NYSE: ELAN] shares were valued at $14.3 at the most recent close of the market. An investor can expect a potential drop of -19.58% based on the average ELAN price forecast.
Analyzing the ELAN fundamentals
According to Elanco Animal Health Inc [NYSE:ELAN], the company’s sales were 4.43B for trailing twelve months, which represents an -1.00% plunge. Gross Profit Margin for this corporation currently stands at 0.46% with Operating Profit Margin at 0.05%, Pretax Profit Margin comes in at 0.12%, and Net Profit Margin reading is 0.08%. To continue investigating profitability, this company’s Return on Assets is posted at 0.03, Equity is 0.06 and Total Capital is 0.02. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.69.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 14.12 points at the first support level, and at 13.93 for the second support level. However, for the 1st resistance point, the stock is sitting at 14.43, and for the 2nd resistance point, it is at 14.55.
Ratios To Look Out For
It is important to note that Elanco Animal Health Inc [NYSE:ELAN] has a current ratio of 2.71. As well, the Quick Ratio is 1.46, while the Cash Ratio is 0.38. Considering the valuation of this stock, the price to sales ratio is 1.60, the price to book ratio is 1.12 and price to earnings (TTM) ratio is 19.08.
Transactions by insiders
Recent insider trading involved Kurzius Lawrence Erik, Director, that happened on Mar 07 ’25 when 10000.0 shares were purchased. Director, Kurzius Lawrence Erik completed a deal on Mar 11 ’25 to buy 10000.0 shares. Meanwhile, Director HOOVER R DAVID bought 25000.0 shares on Mar 05 ’25.
